Improved radionuclide supply can transform nuclear medicine 3 March 2024 Bioscience Today Targeted Alpha Therapy (TAT) is a promising cancer treatment in nuclear medicine, but the supply of alpha-emitting radionuclides – which the treatment relies on – is very limited. A... Continue Reading